The latest market report published by Credence Research “Global ADHD Drugs Market: Growth, Future Prospects, and Competitive Analysis, 2015 – 2027”. The Global ADHD Drugs Market generated revenue of around USD 19,523 million in 2020 and anticipated to grow at a CAGR of over 8.7% during the forecast period from 2021 to 2027 to reach around USD 34,781 million in 2027.
ADHD (Attention deficit hyperactivity disorder) is one of the neurodevelopmental disorders, mainly occurred in children and mostly prevent in males. ADHD is treated with non-stimulant and stimulant drugs. There are some common symptoms of ADHD are kids may forget or lose things, daydream a lot, kids may have a hard time resisting temptation, have difficulty getting along with others, kids are overly active, and have problem paying attention.
Key Trends in Global ADHD Drugs Market
Growing Incidence of ADHD in Children
Children suffering from Attention Deficit Hyperactivity Disorder (ADHD) can increase the number of other disorders, and become a victim of medical depression. A skewed standard of living and the lack of ability to control their impulses could lead to suffering long-term mental illnesses. Thus, it is important to build up effective ADHD drugs for teenagers and children. Moreover, the rising focus of the medical fraternity on the treatment of mental disorders is expected to drive the market growth. Also, the government plays a significant role in developing a strong system for pediatric care.
Browse the full report at https://www.credenceresearch.com/report/adhd-drugs-market
Impact of COVID 19 on ADHD Drugs Market
The ADHD Drug market will exhibit significant growth on the back of the global pandemic. As the result of the COVID-19 outbreak, the disease has spread across the globe and WHO declared it a public health emergency. According to the WHO’s report, the demonstration of COVID-19 has resulted in more than 60.3 million infected individuals across the globe in November 2020. Moreover, due to the COVID-19 pandemic, the governments of various countries are taking initiatives to fight ADHD in children during the COVID-19 pandemic. According to the study published in THE LANCET journal, on April 17, 2020, it was found that during the COVID-19 pandemic, the patients suffering from ADHD have become vulnerable due to the stress caused by the pandemic.
Global ADHD Drugs Market by Drug Type Insights
Stimulant and Non-stimulant are some of the major drug types through ADHD Drug. Stimulant segment accounted for the largest share in 2020 of the ADHD Drugs Market in 2020.
Stimulant Segment to Dominate the Global ADHD Drugs Market
Global ADHD Drugs Market by Age-Group Insights
Adult and Children are the age-group of ADHD Drugs market. In 2020, Adult age-group accounted for the largest share of ADHD Drugs Market.
Global ADHD Drugs Market by Distribution Channel Insights
Global ADHD Drugs Market is segmented based on Distribution Channel as Retail Pharmacy and Hospital Pharmacy. Retail Pharmacy accounted for the largest share of the ADHD Drugs Market in 2020.
Global ADHD Drugs Market by Regional Insights
The North America market is accounted for the highest revenue share and is expected to dominate the global ADHD Drug market over the forecast period. This is attributed to increasing product launches, the large volume of drug prescriptions every year, and the rising collaboration among players to improve market penetration and product development. Europe ADHD drugs market is expected to register the fastest growth rate in the global market, due to rising incidence of attention- hyperactivity disorder, high consumption of preservatives and additives, and rising awareness about mental health.
Global ADHD Drugs Market Competitive Landscape
Most prominent players in the global ADHD Drugs Market include GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc, Amneal Pharmaceuticals, Inc, RespireRx Pharmaceuticals Inc, Noven Pharmaceuticals, Inc, Neos Therapeutics, Inc.,American Brivision (Holding) Corporation, Otsuka Pharmaceutical Co., Ltd, Takeda Pharmaceutical Company Limited, Novartis International AG, Purdue Pharma L.P. and Eli Lilly And Company. The report covers very detailed profiles of these key players.
Market Segmentation
Global ADHD Drugs Market by Drug Type, 2015 – 2027
· Stimulant
· Non-stimulant
Global ADHD Drugs Market by Age-Group, 2015 – 2027
· Adult (Aged 18 and above)
· Children
Global ADHD Drugs Market by Distribution Channel, 2015 – 2027
· Retail Pharmacy
· Hospital Pharmacy
Global ADHD Drugs Market by Region, 2015 – 2027
· North America
· Europe
· Asia Pacific
· Latin America
· Middle East and Africa
Global ADHD Drugs Market: Key Players
· Amneal Pharmaceuticals, Inc
· Eli Lilly And Company
· Janssen Pharmaceuticals, Inc
· Noven Pharmaceuticals, Inc
· RespireRx Pharmaceuticals Inc
· Otsuka Pharmaceutical Co., Ltd
· Neos Therapeutics, Inc.
· American Brivision (Holding) Corporation
· Novartis International AG
· Takeda Pharmaceutical Company Limited
· GlaxoSmithKline plc
· Purdue Pharma L.P.
· Others
Browse the full report at https://www.credenceresearch.com/report/adhd-drugs-market
Related reports:
Media Contact
Company Name: Credence Research
Contact Person: Chris Smith
Email: Send Email
Phone: 18003618290
City: SAN JOSE
State: CA
Country: United States
Website: https://www.credenceresearch.com/